Organization
Oncologia Medica - Ospedale San Bortolo Azienda ULSS8 Berica
4 abstracts
Abstract
Effect of low-dose tamoxifen on IGF-I/IGFBP-3 and estradiol/SHBG ratio and their prognostic/predictive effect in DCIS/LCIS/ADH.Org: E.O. Ospedali Galliera, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, ASL AL Piemonte, Oncologia Medica - Ospedale San Bortolo Azienda ULSS8 Berica, Romagna Local Health Authority,
Abstract
Intermittent or continuous panitumumab plus FOLFIRI (FOLFIRI/PANI) for first-line treatment of patients (pts) with RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC): An update of survival/toxicity and preliminary results of genomic alterations from IMPROVE study.Org: Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, National Cancer Research Centre, Istituto Tumori “Giovanni Paolo II”, Istituto Nazionale Tumori Fondazione G. Pascale, AORN DEI Colli - Monaldi Hospital,
Abstract
Epidemiological and clinicopathological features of patients (pts) with early- (EOPC) and late-onset pancreatic cancer (LOPC): A mono-institutional retrospective analysis.Org: Oncologia Medica - Ospedale San Bortolo Azienda ULSS8 Berica, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland, Fondazione Policlinico Universitario Agostino Gemelli–IRCCS, Università Cattolica del Sacro Cuore, Real World Data Facility,
Abstract
Focus on RAS codon 61 mutations in metastatic colorectal cancer (mCRC): A retrospective analysis.Org: Oncologia Medica - Ospedale San Bortolo Azienda ULSS8 Berica, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Romark Laboratories,